Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02)

World Biggest Tenders Source

This tender with title Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) -- Endocrine therapy medicinal products has been published on Bidding Source portal dated 05 Apr 2022 for the country of Germany. It has been categorized on Endocrine therapy medicinal products. For similar tenders you can see tenders mentioned below of this page.

Endocrine therapy medicinal products

General Information

Germany

Tender Title :

Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02)
Endocrine therapy medicinal products

Tender Type :

Invitation for Bids

Reference No. :

2022/S 066-173701

Country :

Germany

Province/City :

Germany-Hanover

Publish Date :

5 Apr 2022

Closing Date :

26 Mar 2024

Notice Language :

English

Tender Categories (CPVs) :

Endocrine therapy medicinal products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Germany - Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient fulvestrant (ATC code: L02BA03). -- <br><b>Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03).</b> Germany Endocrine therapy medicinal products - Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02) Germany Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Fulvestrant (ATC-Code: L02BA03) Germany Germany-Hanover: Endocrine therapy medicinal products Germany Tender for the supply of Abiraterone - No. Diag. 51/2025 (OAY) - 12595 Cyprus Endocrine therapy medicinal products – Medicine supplies – Active substance darolutamide – ATC L02BB06 - 108303 Czech Republic Buying of Endocrine system drugs - 09234 Uruguay Execution of works to achieve the investment objective: ESTABLISHMENT OF DRINKING WATER NETWORKS AND WATER MANAGEMENT AND DOMESTIC SEWERAGE NETWORK AND TREATMENT PLANT IN SMARDIOASA COMMUNITY, TELEORMAN COUNTY - 98308 Romania Artistic services – Protection and presentation of the collection funds of the Hussite Museum in Tábor – Korouhve 1 - 101386 Czech Republic Appointment of designer for the design of the Keerdok swimming area, the redevelopment of the jetty and the redevelopment of the marina - 100332 Belgium

Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Leuprorelin (ATC-Code: L02AE02)

Endocrine therapy medicinal products

General Information

Germany

Similar Tenders

Endocrine therapy medicinal products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com